Iris Acquisition II Corp（IRAB）股票分析

AI 分析 of Iris Acquisition II Corp (IRAB)

持有

Iris Acquisition II Corp (IRAB) is currently priced at $10.03, showing a 52-week high of $10.17 and a low of $9.81, indicating it is near the upper end of its range. The RSI is at 61.741, suggesting it is approaching overbought territory, which may limit short-term upside. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, while the stock has shown a 1.62% year-to-date increase. However, the net income for the last two quarters has been positive, with $1,263,575 reported in Q2 2026. The main risk is the high P/E ratio of 116.76, which may indicate overvaluation if earnings do not improve significantly. Therefore, while there are some positive indicators, the lack of consistent financial performance and high valuation metrics suggest holding rather than buying at this time.

估值指標

Iris Acquisition II Corp（IRAB）目前預期本益比為 0.00，5 年平均預期本益比為。

預期本益比

5 年均值 P/E

目前P/E

0.00

預期 EV/EBITDA

5 年均值 EV/EBITDA

目前EV/EBITDA

0.00

預期股價營收比

5 年均值 P/S

目前P/S

0.00

持有 IRAB 的大戶

C

Cable Car Capital LLC

+ 持有IRAB

-4.58%

3個月報酬率

A

Aristeia Capital, LLC

+ 持有IRAB

-5.59%

3個月報酬率

IRAB 常見問題 —— 由 Alphio AI 解答

Iris Acquisition Corp II, located in Dubai, the United Arab Emirates, is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. It operates in the Financials sector.

Iris Acquisition II Corp (IRAB) is currently priced at $10.03, showing a 52-week high of $10.17 and a low of $9.81, indicating it is near the upper end of its range. The RSI is at 61.741, suggesting it is approaching overbought territory, which may limit short-term upside. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, while the stock has shown a 1.62% year-to-date increase. However, the net income for the last two quarters has been positive, with $1,263,575 reported in Q2 2026. The main risk is the high P/E ratio of 116.76, which may indicate overvaluation if earnings do not improve significantly. Therefore, while there are some positive indicators, the lack of consistent financial performance and high valuation metrics suggest holding rather than buying at this time.